Active Ingredient: LAMIVUDINE; ZIDOVUDINE
Proprietary Name: LAMIVUDINE AND ZIDOVUDINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 150MG;300MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A079079
Product Number: 001
Approval Date: Aug 12, 2019
Applicant Holder Full Name: MYLAN LABORATORIES LTD
Marketing Status:
Discontinued
Patent and Exclusivity Information
